Tattooing suspicious axillary lymph nodes in breast cancer patients treated by primary systemic therapy
- PI: Steffi Hartmann (MD)
- study initiated by EUBREAST
- Kind of trial: prospective feasibility trial
- Primary study endpoint: Detection rate of charcoal tattooed axillary lymph nodes during surgery after primary systemic therapy in breast cancer patients.
- Publication Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial
